Cubist Pharmaceuticals 1Q10 Total Net Revenues Up ...

Reconfirmed at $627 ? $652 Million GAAP Basic and Diluted Net Income of $0.35 and $0.34 Per Share, Respectively, for 1Q10 NON-GAAP Basic and...